372 related articles for article (PubMed ID: 34063108)
1. Gut Microbiota as Potential Biomarker and/or Therapeutic Target to Improve the Management of Cancer: Focus on Colibactin-Producing
Veziant J; Villéger R; Barnich N; Bonnet M
Cancers (Basel); 2021 May; 13(9):. PubMed ID: 34063108
[TBL] [Abstract][Full Text] [Related]
2. Autophagy of Intestinal Epithelial Cells Inhibits Colorectal Carcinogenesis Induced by Colibactin-Producing Escherichia coli in Apc
Lucas C; Salesse L; Hoang MHT; Bonnet M; Sauvanet P; Larabi A; Godfraind C; Gagnière J; Pezet D; Rosenstiel P; Barnich N; Bonnet R; Dalmasso G; Nguyen HTT
Gastroenterology; 2020 Apr; 158(5):1373-1388. PubMed ID: 31917256
[TBL] [Abstract][Full Text] [Related]
3. Colibactin-Producing
Salesse L; Lucas C; Hoang MHT; Sauvanet P; Rezard A; Rosenstiel P; Damon-Soubeyrand C; Barnich N; Godfraind C; Dalmasso G; Nguyen HTT
Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33923277
[TBL] [Abstract][Full Text] [Related]
4. Diet-mediated gut microbial community modulation and signature metabolites as potential biomarkers for early diagnosis, prognosis, prevention and stage-specific treatment of colorectal cancer.
John Kenneth M; Tsai HC; Fang CY; Hussain B; Chiu YC; Hsu BM
J Adv Res; 2023 Oct; 52():45-57. PubMed ID: 36596411
[TBL] [Abstract][Full Text] [Related]
5. Colibactin-positive Escherichia coli induce a procarcinogenic immune environment leading to immunotherapy resistance in colorectal cancer.
Lopès A; Billard E; Casse AH; Villéger R; Veziant J; Roche G; Carrier G; Sauvanet P; Briat A; Pagès F; Naimi S; Pezet D; Barnich N; Dumas B; Bonnet M
Int J Cancer; 2020 Jun; 146(11):3147-3159. PubMed ID: 32037530
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic necrotizing factor 1 hinders colon tumorigenesis induced by colibactin-producing
Chat H; Dalmasso G; Godfraind C; Bonnin V; Beyrouthy R; Bonnet M; Barnich N; Mettouchi A; Lemichez E; Bonnet R; Delmas J
Gut Microbes; 2023; 15(1):2229569. PubMed ID: 37417545
[TBL] [Abstract][Full Text] [Related]
7. ATG16L1 in myeloid cells limits colorectal tumor growth in
Salesse L; Duval A; Sauvanet P; Da Silva A; Barnich N; Godfraind C; Dalmasso G; Nguyen HTT
Autophagy; 2024 Jun; ():1-19. PubMed ID: 38818900
[No Abstract] [Full Text] [Related]
8. Colibactin-producing
Dalmasso G; Cougnoux A; Faïs T; Bonnin V; Mottet-Auselo B; Nguyen HT; Sauvanet P; Barnich N; Jary M; Pezet D; Delmas J; Bonnet R
Gut Microbes; 2024; 16(1):2310215. PubMed ID: 38374654
[TBL] [Abstract][Full Text] [Related]
9. Gut Microbiota in Colorectal Cancer: Biological Role and Therapeutic Opportunities.
Pandey H; Tang DWT; Wong SH; Lal D
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765824
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota imbalance and colorectal cancer.
Gagnière J; Raisch J; Veziant J; Barnich N; Bonnet R; Buc E; Bringer MA; Pezet D; Bonnet M
World J Gastroenterol; 2016 Jan; 22(2):501-18. PubMed ID: 26811603
[TBL] [Abstract][Full Text] [Related]
11. The colibactin-producing
de Oliveira Alves N; Dalmasso G; Nikitina D; Vaysse A; Ruez R; Ledoux L; Pedron T; Bergsten E; Boulard O; Autier L; Allam S; Motreff L; Sauvanet P; Letourneur D; Kashyap P; Gagnière J; Pezet D; Godfraind C; Salzet M; Lemichez E; Bonnet M; Najjar I; Malabat C; Monot M; Mestivier D; Barnich N; Yadav P; Fournier I; Kennedy S; Mettouchi A; Bonnet R; Sobhani I; Chamaillard M
Gut Microbes; 2024; 16(1):2320291. PubMed ID: 38417029
[TBL] [Abstract][Full Text] [Related]
12. The bacterial genotoxin colibactin promotes colon tumor growth by modifying the tumor microenvironment.
Dalmasso G; Cougnoux A; Delmas J; Darfeuille-Michaud A; Bonnet R
Gut Microbes; 2014; 5(5):675-80. PubMed ID: 25483338
[TBL] [Abstract][Full Text] [Related]
13. The Food Contaminant Deoxynivalenol Exacerbates the Genotoxicity of Gut Microbiota.
Payros D; Dobrindt U; Martin P; Secher T; Bracarense AP; Boury M; Laffitte J; Pinton P; Oswald E; Oswald IP
mBio; 2017 Mar; 8(2):. PubMed ID: 28292979
[TBL] [Abstract][Full Text] [Related]
14. Three specific gut bacteria in the occurrence and development of colorectal cancer: a concerted effort.
Gong D; Adomako-Bonsu AG; Wang M; Li J
PeerJ; 2023; 11():e15777. PubMed ID: 37554340
[TBL] [Abstract][Full Text] [Related]
15. Fusobacterium and Escherichia: models of colorectal cancer driven by microbiota and the utility of microbiota in colorectal cancer screening.
Leung A; Tsoi H; Yu J
Expert Rev Gastroenterol Hepatol; 2015 May; 9(5):651-7. PubMed ID: 25582922
[TBL] [Abstract][Full Text] [Related]
16. Impact of microbiota in colorectal carcinogenesis: lessons from experimental models.
Yu LC; Wei SC; Ni YH
Intest Res; 2018 Jul; 16(3):346-357. PubMed ID: 30090033
[TBL] [Abstract][Full Text] [Related]
17. Microbial imbalance and intestinal pathologies: connections and contributions.
Yang Y; Jobin C
Dis Model Mech; 2014 Oct; 7(10):1131-42. PubMed ID: 25256712
[TBL] [Abstract][Full Text] [Related]
18. [Gut microbiota: What impact on colorectal carcinogenesis and treatment?].
Bruneau A; Baylatry MT; Joly AC; Sokol H
Bull Cancer; 2018 Jan; 105(1):70-80. PubMed ID: 29217301
[TBL] [Abstract][Full Text] [Related]
19. Microbiota Effects on Carcinogenesis: Initiation, Promotion, and Progression.
Lopez LR; Bleich RM; Arthur JC
Annu Rev Med; 2021 Jan; 72():243-261. PubMed ID: 33052764
[TBL] [Abstract][Full Text] [Related]
20. Effect of gut microbiota in the colorectal cancer and potential target therapy.
Li J; Zhu Y; Yang L; Wang Z
Discov Oncol; 2022 Jun; 13(1):51. PubMed ID: 35749000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
